ALLR - Allarity Therapeutics says no longer in compliance with Nasdaq listing rules

Allarity Therapeutics (NASDAQ:ALLR) on Friday said it got a Nasdaq notice on April 20 that it was no longer in compliance with listing rules due to delay in its 10-K filing for the fiscal year ended Dec. 31, 2021. ALLR has 60 days to submit to Nasdaq a plan to regain compliance. If Nasdaq accepts the plan, ALLR can get up to 180 days from the form 10-K's due date to regain compliance. The clinical-stage pharmaceutical company said it expects to file the form 10-K within the 60-day period, which ends on June 19. ALLR stock earlier closed +1% at $2.02.

For further details see:

Allarity Therapeutics says no longer in compliance with Nasdaq listing rules